After the number of COVID-19 infections began to incline steeply, India has decided to retain most of the vaccines produced in the country. The country has also announced plans to lower the eligibility requirements to all citizens 45 or older starting April 1. The Serum Institute of India is one of the world’s biggest vaccine…
India authorizes 2 COVID-19 vaccines
India is allowing reserved emergency use of the AstraZeneca (LON:AZN) COVID-19 vaccine and another from the domestic firm Bharat Biotech. The country is producing both vaccines internally. Serum Institute of India has a contract to manufacture the AstraZeneca vaccine and has stockpiled between 40 and 50 million doses. Covaxin, the vaccine from Bharat Biotech, was…